Evidence map›Paper›PMID 29238697›Full record

ReviewFrontiers in oncology2017

Ataxia-Telangiectasia Mutated Modulation of Carbon Metabolism in Cancer.

Erika S Dahl, Katherine M Aird

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Interplay between altered metabolism and DNA damage and repair in ovarian cancer.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Experimental Setups for In Vitro Studies on Radon Exposure in Mammalian Cells-A Critical Overview.International journal of environmental research and public health · 2023
    Review
  11. Review
  12. Article
  13. PathIN: an integrated tool for the visualization of pathway interaction networks.Computational and structural biotechnology journal · 2023
    Article
  14. Article
  15. Article
  16. Review
  17. ATM Modulates Nuclear Mechanics by Regulating Lamin A Levels.Frontiers in cell and developmental biology · 2022
    Article
  18. p53 signaling in cancer progression and therapy.Cancer cell international · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Erika S DahlDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, United States.
Katherine M AirdDepartment of Cellular and Molecular Physiology, Penn State College of Medicine, Hershey, PA, United States.
Penn State Milton S. Hershey Medical Center · US

Funding

Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian CancerR00CA194309 · NCI · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI AIRD, KATHERINE MARIE · 2017 to 2019
$697k
NCI NIH HHS R00 CA194309
6 · The paper itself

Abstract

The ataxia-telangiectasia mutated (ATM) protein kinase has been extensively studied for its role in the DNA damage response and its association with the disease ataxia telangiectasia. There is increasing evidence that ATM also plays an important role in other cellular processes, including carbon metabolism. Carbon metabolism is highly dysregulated in cancer due to the increased need for cellular biomass. A number of recent studies report a non-canonical role for ATM in the regulation of carbon metabolism. This review highlights what is currently known about ATM's regulation of carbon metabolism, the implication of these pathways in cancer, and the development of ATM inhibitors as therapeutic strategies for cancer.

Indexed as

AKTataxia-telangiectasia mutatedcancercellular metabolismc-mycp53reactive oxygen speciessenescence

Identifiers

PMID29238697
PMCPMC5712564
OpenAlexW2770278344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.